Crossmark

Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival

Crossref DOI link: https://doi.org/10.1007/s10549-022-06808-9

Published Online: 2022-11-23

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carmen, Albertini

Anne, Oberguggenberger https://orcid.org/0000-0002-9377-4771
Monika, Sztankay

Daniel, Egle

Johannes, Giesinger

Verena, Meraner

Michael, Hubalek

Christine, Brunner
Funding

Funding for this research was provided by:

University of Innsbruck and Medical University of Innsbruck
License Information

Text and Data Mining valid from 2022-11-23

Version of Record valid from 2022-11-23
More Information

Article History

Received: 9 April 2022

Accepted: 9 November 2022

First Online: 23 November 2022

Declarations

:

: The authors declare that they have no conflict of interest. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

Document is current

Any future updates will be listed below